Global Companion Diagnostic Cancer Biomarkers Market Report 2019, Competitive Landscape, Trends and Opportunities
The Companion Diagnostic Cancer Biomarkers market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Companion Diagnostic Cancer Biomarkers market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Companion Diagnostic Cancer Biomarkers market.
Major players in the global Companion Diagnostic Cancer Biomarkers market include:
Arup Laboratories Inc.
Hoffmann-La Roche AG
Illumina, Inc.
Myriad Genetics, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Biom?rieux SA
Danaher Corporation
Abbott Laboratories, Inc.
Qiagen N.V.
On the basis of types, the Companion Diagnostic Cancer Biomarkers market is primarily split into:
Protein Biomarkers
Genetic Biomarkers
Other Cancer Biomarkers
On the basis of applications, the market covers:
Breast Cancer
Lung Cancer
Melanoma
Colorectal Cancer
Gastric
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Companion Diagnostic Cancer Biomarkers market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Companion Diagnostic Cancer Biomarkers market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Companion Diagnostic Cancer Biomarkers industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Companion Diagnostic Cancer Biomarkers market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Companion Diagnostic Cancer Biomarkers, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Companion Diagnostic Cancer Biomarkers in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Companion Diagnostic Cancer Biomarkers in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Companion Diagnostic Cancer Biomarkers. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Companion Diagnostic Cancer Biomarkers market, including the global production and revenue forecast, regional forecast. It also foresees the Companion Diagnostic Cancer Biomarkers market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Companion Diagnostic Cancer Biomarkers market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Companion Diagnostic Cancer Biomarkers market.
Major players in the global Companion Diagnostic Cancer Biomarkers market include:
Arup Laboratories Inc.
Hoffmann-La Roche AG
Illumina, Inc.
Myriad Genetics, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Biom?rieux SA
Danaher Corporation
Abbott Laboratories, Inc.
Qiagen N.V.
On the basis of types, the Companion Diagnostic Cancer Biomarkers market is primarily split into:
Protein Biomarkers
Genetic Biomarkers
Other Cancer Biomarkers
On the basis of applications, the market covers:
Breast Cancer
Lung Cancer
Melanoma
Colorectal Cancer
Gastric
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Companion Diagnostic Cancer Biomarkers market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Companion Diagnostic Cancer Biomarkers market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Companion Diagnostic Cancer Biomarkers industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Companion Diagnostic Cancer Biomarkers market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Companion Diagnostic Cancer Biomarkers, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Companion Diagnostic Cancer Biomarkers in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Companion Diagnostic Cancer Biomarkers in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Companion Diagnostic Cancer Biomarkers. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Companion Diagnostic Cancer Biomarkers market, including the global production and revenue forecast, regional forecast. It also foresees the Companion Diagnostic Cancer Biomarkers market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 COMPANION DIAGNOSTIC CANCER BIOMARKERS MARKET OVERVIEW
1.1 Product Overview and Scope of Companion Diagnostic Cancer Biomarkers
1.2 Companion Diagnostic Cancer Biomarkers Segment by Type
1.2.1 Global Companion Diagnostic Cancer Biomarkers Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Protein Biomarkers
1.2.3 The Market Profile of Genetic Biomarkers
1.2.4 The Market Profile of Other Cancer Biomarkers
1.3 Global Companion Diagnostic Cancer Biomarkers Segment by Application
1.3.1 Companion Diagnostic Cancer Biomarkers Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Breast Cancer
1.3.3 The Market Profile of Lung Cancer
1.3.4 The Market Profile of Melanoma
1.3.5 The Market Profile of Colorectal Cancer
1.3.6 The Market Profile of Gastric
1.3.7 The Market Profile of Others
1.4 Global Companion Diagnostic Cancer Biomarkers Market by Region (2014-2026)
1.4.1 Global Companion Diagnostic Cancer Biomarkers Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3 Europe Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.1 Germany Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.2 UK Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.3 France Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.4 Italy Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.5 Spain Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.6 Russia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.7 Poland Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.4 China Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.5 Japan Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.6 India Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8 Central and South America Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Companion Diagnostic Cancer Biomarkers (2014-2026)
1.5.1 Global Companion Diagnostic Cancer Biomarkers Revenue Status and Outlook (2014-2026)
1.5.2 Global Companion Diagnostic Cancer Biomarkers Production Status and Outlook (2014-2026)
2 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS MARKET LANDSCAPE BY PLAYER
2.1 Global Companion Diagnostic Cancer Biomarkers Production and Share by Player (2014-2019)
2.2 Global Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Player (2014-2019)
2.3 Global Companion Diagnostic Cancer Biomarkers Average Price by Player (2014-2019)
2.4 Companion Diagnostic Cancer Biomarkers Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Companion Diagnostic Cancer Biomarkers Market Competitive Situation and Trends
2.5.1 Companion Diagnostic Cancer Biomarkers Market Concentration Rate
2.5.2 Companion Diagnostic Cancer Biomarkers Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Arup Laboratories Inc.
3.1.1 Arup Laboratories Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.1.3 Arup Laboratories Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.1.4 Arup Laboratories Inc. Business Overview
3.2 Hoffmann-La Roche AG
3.2.1 Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.2.3 Hoffmann-La Roche AG Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.2.4 Hoffmann-La Roche AG Business Overview
3.3 Illumina, Inc.
3.3.1 Illumina, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.3.3 Illumina, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.3.4 Illumina, Inc. Business Overview
3.4 Myriad Genetics, Inc.
3.4.1 Myriad Genetics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.4.3 Myriad Genetics, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.4.4 Myriad Genetics, Inc. Business Overview
3.5 Agilent Technologies, Inc.
3.5.1 Agilent Technologies, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.5.3 Agilent Technologies, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.5.4 Agilent Technologies, Inc. Business Overview
3.6 Thermo Fisher Scientific Inc.
3.6.1 Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.6.3 Thermo Fisher Scientific Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.6.4 Thermo Fisher Scientific Inc. Business Overview
3.7 Biom?rieux SA
3.7.1 Biom?rieux SA Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.7.3 Biom?rieux SA Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.7.4 Biom?rieux SA Business Overview
3.8 Danaher Corporation
3.8.1 Danaher Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.8.3 Danaher Corporation Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.8.4 Danaher Corporation Business Overview
3.9 Abbott Laboratories, Inc.
3.9.1 Abbott Laboratories, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.9.3 Abbott Laboratories, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.9.4 Abbott Laboratories, Inc. Business Overview
3.10 Qiagen N.V.
3.10.1 Qiagen N.V. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.10.3 Qiagen N.V. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.10.4 Qiagen N.V. Business Overview
4 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Companion Diagnostic Cancer Biomarkers Production and Market Share by Type (2014-2019)
4.2 Global Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Type (2014-2019)
4.3 Global Companion Diagnostic Cancer Biomarkers Price by Type (2014-2019)
4.4 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate by Type (2014-2019)
4.4.1 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate of Protein Biomarkers (2014-2019)
4.4.2 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate of Genetic Biomarkers (2014-2019)
4.4.3 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate of Other Cancer Biomarkers (2014-2019)
5 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS MARKET ANALYSIS BY APPLICATION
5.1 Global Companion Diagnostic Cancer Biomarkers Consumption and Market Share by Application (2014-2019)
5.2 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Breast Cancer (2014-2019)
5.2.2 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Lung Cancer (2014-2019)
5.2.3 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Melanoma (2014-2019)
5.2.4 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Colorectal Cancer (2014-2019)
5.2.5 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Gastric (2014-2019)
5.2.6 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Others (2014-2019)
6 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Companion Diagnostic Cancer Biomarkers Consumption by Region (2014-2019)
6.2 United States Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.3 Europe Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.4 China Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.5 Japan Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.6 India Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
7 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Companion Diagnostic Cancer Biomarkers Production and Market Share by Region (2014-2019)
7.2 Global Companion Diagnostic Cancer Biomarkers Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
8 COMPANION DIAGNOSTIC CANCER BIOMARKERS MANUFACTURING ANALYSIS
8.1 Companion Diagnostic Cancer Biomarkers Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Companion Diagnostic Cancer Biomarkers
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Companion Diagnostic Cancer Biomarkers Industrial Chain Analysis
9.2 Raw Materials Sources of Companion Diagnostic Cancer Biomarkers Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Companion Diagnostic Cancer Biomarkers
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS MARKET FORECAST (2019-2026)
11.1 Global Companion Diagnostic Cancer Biomarkers Production, Revenue Forecast (2019-2026)
11.1.1 Global Companion Diagnostic Cancer Biomarkers Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Companion Diagnostic Cancer Biomarkers Price and Trend Forecast (2019-2026)
11.2 Global Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Companion Diagnostic Cancer Biomarkers Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Companion Diagnostic Cancer Biomarkers Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Companion Diagnostic Cancer Biomarkers
1.2 Companion Diagnostic Cancer Biomarkers Segment by Type
1.2.1 Global Companion Diagnostic Cancer Biomarkers Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Protein Biomarkers
1.2.3 The Market Profile of Genetic Biomarkers
1.2.4 The Market Profile of Other Cancer Biomarkers
1.3 Global Companion Diagnostic Cancer Biomarkers Segment by Application
1.3.1 Companion Diagnostic Cancer Biomarkers Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Breast Cancer
1.3.3 The Market Profile of Lung Cancer
1.3.4 The Market Profile of Melanoma
1.3.5 The Market Profile of Colorectal Cancer
1.3.6 The Market Profile of Gastric
1.3.7 The Market Profile of Others
1.4 Global Companion Diagnostic Cancer Biomarkers Market by Region (2014-2026)
1.4.1 Global Companion Diagnostic Cancer Biomarkers Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3 Europe Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.1 Germany Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.2 UK Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.3 France Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.4 Italy Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.5 Spain Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.6 Russia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.3.7 Poland Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.4 China Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.5 Japan Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.6 India Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8 Central and South America Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Companion Diagnostic Cancer Biomarkers Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Companion Diagnostic Cancer Biomarkers (2014-2026)
1.5.1 Global Companion Diagnostic Cancer Biomarkers Revenue Status and Outlook (2014-2026)
1.5.2 Global Companion Diagnostic Cancer Biomarkers Production Status and Outlook (2014-2026)
2 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS MARKET LANDSCAPE BY PLAYER
2.1 Global Companion Diagnostic Cancer Biomarkers Production and Share by Player (2014-2019)
2.2 Global Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Player (2014-2019)
2.3 Global Companion Diagnostic Cancer Biomarkers Average Price by Player (2014-2019)
2.4 Companion Diagnostic Cancer Biomarkers Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Companion Diagnostic Cancer Biomarkers Market Competitive Situation and Trends
2.5.1 Companion Diagnostic Cancer Biomarkers Market Concentration Rate
2.5.2 Companion Diagnostic Cancer Biomarkers Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Arup Laboratories Inc.
3.1.1 Arup Laboratories Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.1.3 Arup Laboratories Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.1.4 Arup Laboratories Inc. Business Overview
3.2 Hoffmann-La Roche AG
3.2.1 Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.2.3 Hoffmann-La Roche AG Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.2.4 Hoffmann-La Roche AG Business Overview
3.3 Illumina, Inc.
3.3.1 Illumina, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.3.3 Illumina, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.3.4 Illumina, Inc. Business Overview
3.4 Myriad Genetics, Inc.
3.4.1 Myriad Genetics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.4.3 Myriad Genetics, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.4.4 Myriad Genetics, Inc. Business Overview
3.5 Agilent Technologies, Inc.
3.5.1 Agilent Technologies, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.5.3 Agilent Technologies, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.5.4 Agilent Technologies, Inc. Business Overview
3.6 Thermo Fisher Scientific Inc.
3.6.1 Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.6.3 Thermo Fisher Scientific Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.6.4 Thermo Fisher Scientific Inc. Business Overview
3.7 Biom?rieux SA
3.7.1 Biom?rieux SA Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.7.3 Biom?rieux SA Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.7.4 Biom?rieux SA Business Overview
3.8 Danaher Corporation
3.8.1 Danaher Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.8.3 Danaher Corporation Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.8.4 Danaher Corporation Business Overview
3.9 Abbott Laboratories, Inc.
3.9.1 Abbott Laboratories, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.9.3 Abbott Laboratories, Inc. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.9.4 Abbott Laboratories, Inc. Business Overview
3.10 Qiagen N.V.
3.10.1 Qiagen N.V. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Companion Diagnostic Cancer Biomarkers Product Profiles, Application and Specification
3.10.3 Qiagen N.V. Companion Diagnostic Cancer Biomarkers Market Performance (2014-2019)
3.10.4 Qiagen N.V. Business Overview
4 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Companion Diagnostic Cancer Biomarkers Production and Market Share by Type (2014-2019)
4.2 Global Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Type (2014-2019)
4.3 Global Companion Diagnostic Cancer Biomarkers Price by Type (2014-2019)
4.4 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate by Type (2014-2019)
4.4.1 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate of Protein Biomarkers (2014-2019)
4.4.2 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate of Genetic Biomarkers (2014-2019)
4.4.3 Global Companion Diagnostic Cancer Biomarkers Production Growth Rate of Other Cancer Biomarkers (2014-2019)
5 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS MARKET ANALYSIS BY APPLICATION
5.1 Global Companion Diagnostic Cancer Biomarkers Consumption and Market Share by Application (2014-2019)
5.2 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Breast Cancer (2014-2019)
5.2.2 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Lung Cancer (2014-2019)
5.2.3 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Melanoma (2014-2019)
5.2.4 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Colorectal Cancer (2014-2019)
5.2.5 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Gastric (2014-2019)
5.2.6 Global Companion Diagnostic Cancer Biomarkers Consumption Growth Rate of Others (2014-2019)
6 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Companion Diagnostic Cancer Biomarkers Consumption by Region (2014-2019)
6.2 United States Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.3 Europe Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.4 China Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.5 Japan Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.6 India Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Companion Diagnostic Cancer Biomarkers Production, Consumption, Export, Import (2014-2019)
7 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Companion Diagnostic Cancer Biomarkers Production and Market Share by Region (2014-2019)
7.2 Global Companion Diagnostic Cancer Biomarkers Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Companion Diagnostic Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
8 COMPANION DIAGNOSTIC CANCER BIOMARKERS MANUFACTURING ANALYSIS
8.1 Companion Diagnostic Cancer Biomarkers Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Companion Diagnostic Cancer Biomarkers
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Companion Diagnostic Cancer Biomarkers Industrial Chain Analysis
9.2 Raw Materials Sources of Companion Diagnostic Cancer Biomarkers Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Companion Diagnostic Cancer Biomarkers
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL COMPANION DIAGNOSTIC CANCER BIOMARKERS MARKET FORECAST (2019-2026)
11.1 Global Companion Diagnostic Cancer Biomarkers Production, Revenue Forecast (2019-2026)
11.1.1 Global Companion Diagnostic Cancer Biomarkers Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Companion Diagnostic Cancer Biomarkers Price and Trend Forecast (2019-2026)
11.2 Global Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Companion Diagnostic Cancer Biomarkers Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Companion Diagnostic Cancer Biomarkers Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Companion Diagnostic Cancer Biomarkers Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
